| Name: | Portola Pharmaceuticals, Inc. |
| Jurisdiction: | Alaska |
| Legal type: | Business Corporation |
| Status: | Revoked |
| Date of registration: | 27 Jun 2011 (14 years ago) |
| Entity Number: | 136222 |
| Place of Formation: | DELAWARE |
| Address: | 270 East Grand Avenue, SOUTH SAN FRANCISCO, CA 94080 |
| Name | Role | Shares |
|---|---|---|
| REGISTERED AGENTS SOLUTIONS, INC | Registered Agent | - |
| Abingworth Bioventures IV LP | Shareholder | 5.42 |
| Advanced Technology Ventures, VII, LP | Shareholder | 6.38 |
| Anjali Pandey, Ph.D | Vice President | - |
| Brookside Capital Partners Fund LP | Shareholder | 7.86 |
| Charles Homcy, MD | Director | - |
| Farah Champsi | Director | - |
| Frazier Healthcare IV, LP | Shareholder | 6.29 |
| H. Ward Wolff | Director | - |
| Hollings C. Renton | Director | - |
Date of last update: 16 Feb 2025
Sources: State of Alaska - Department of Commerce, Community, and Economic Development
